Approval · Notice of Compliance 38440 · 2026
JAMP ELTROMBOPAG: Notice of Compliance 38440
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38440
- Date
- October 9, 2026
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- REVOLADE (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP ELTROMBOPAG | 02752591 | — |
| JAMP ELTROMBOPAG | 02572605 | — |
Medicinal ingredients
- ELTROMBOPAG OLAMINE 25 MG per TAB
- ELTROMBOPAG OLAMINE 50 MG per TAB